BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
88 results:

  • 1. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
    Li S; Li J; Yang Q; Yin C; Liu B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic Dissection.
    Roshan A; Shah B; Anderson KD; Murphy S; Thomas B; McPhee AS; Lamb BW; Durrani AJ; Patel AJK
    Ann Surg Oncol; 2024 Apr; 31(4):2727-2736. PubMed ID: 38177461
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
    Strowd R; Ellingson B; Raymond C; Yao J; Wen PY; Ahluwalia M; Piotrowski A; Desai A; Clarke JL; Lieberman FS; Desideri S; Nabors LB; Ye X; Grossman S
    J Neurooncol; 2023 Oct; 165(1):101-112. PubMed ID: 37864646
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
    Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
    World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.
    Peng Y; Ren Y; Huang B; Tang J; Jv Y; Mao Q; Liu Y; Lei Y; Zhang Y
    Sci Rep; 2023 Jun; 13(1):9970. PubMed ID: 37340065
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study.
    Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J
    Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Histogram array and convolutional neural network of DWI for differentiating pancreatic ductal adenocarcinomas from solid pseudopapillary neoplasms and neuroendocrine neoplasms.
    Shi YJ; Zhu HT; Li XT; Zhang XY; Liu YL; Wei YY; Sun YS
    Clin Imaging; 2023 Apr; 96():15-22. PubMed ID: 36736182
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
    Abdelazeem B; Abbas KS; Shehata J; El-Shahat NA; Eltaras MM; Qaddoumi I; Alfaar AS
    Cancer Med; 2023 Mar; 12(5):6318-6324. PubMed ID: 36479934
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor.
    Huang XT; Xie JZ; Huang CS; Li JH; Chen W; Liang LJ; Yin XY
    HPB (Oxford); 2022 Dec; 24(12):2112-2118. PubMed ID: 36127226
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Reduction of phosphorylated α-synuclein through downregulation of casein kinase 2α alleviates dopaminergic-neuronal function.
    Potdar C; Kaushal A; Raj A; Mallick R; Datta I
    Biochem Biophys Res Commun; 2022 Jul; 615():43-48. PubMed ID: 35605404
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy of a Deep Learning Convolutional Neural Network System for Melanoma Diagnosis in a Hospital Population.
    Martin-Gonzalez M; Azcarraga C; Martin-Gil A; Carpena-Torres C; Jaen P
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409575
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cellular Telephone Use and the Risk of Brain tumors: Update of the UK Million Women Study.
    Schüz J; Pirie K; Reeves GK; Floud S; Beral V;
    J Natl Cancer Inst; 2022 May; 114(5):704-711. PubMed ID: 35350069
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Does sex matter? Analysis of sex-related differences in the diagnostic performance of a market-approved convolutional neural network for skin cancer detection.
    Sies K; Winkler JK; Fink C; Bardehle F; Toberer F; Buhl T; Enk A; Blum A; Stolz W; Rosenberger A; Haenssle HA
    Eur J Cancer; 2022 Mar; 164():88-94. PubMed ID: 35182926
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypofractionated Radiation Therapy For Diffuse Intrinsic Pontine Glioma: A Noninferiority Randomized Study Including 253 Children.
    Zaghloul MS; Nasr A; Tolba M; Refaat A; Youssef A; Mosaab A; Enayet A; Arafa O; Maher E; Eldebawy E
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):360-368. PubMed ID: 35150788
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A two-stage network with prior knowledge guidance for medullary thyroid carcinoma recognition in ultrasound images.
    Pan L; Cai Y; Lin N; Yang L; Zheng S; Huang L
    Med Phys; 2022 Apr; 49(4):2413-2426. PubMed ID: 35103313
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database.
    Xu MN; Rao Q
    Dermatology; 2022; 238(3):534-541. PubMed ID: 34818654
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma.
    Brendlin AS; Peisen F; Almansour H; Afat S; Eigentler T; Amaral T; Faby S; Calvarons AF; Nikolaou K; Othman AE
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34795006
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Selected polyoxopalladates as promising and selective antitumor drug candidates.
    Isakovic AM; Čolović MB; Ma T; Ma X; Jeremic M; Gerić M; Gajski G; Misirlic-Dencic S; Kortz U; Krstić D
    J Biol Inorg Chem; 2021 Dec; 26(8):957-971. PubMed ID: 34549367
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Assessment of the AJCC staging system of pheochromocytomas/paragangliomas.
    Abdel-Rahman O
    Endocrine; 2022 Jan; 75(1):239-243. PubMed ID: 34449032
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.